ResearcherGuiyang Medical UniversityActive in the last 2 years

Yongjia Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-6483-798X; OpenAlex author ID A5077377909. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2024: 2 papers · 2025: 1 paper

Papers 3

PSMD14-Mediated LDHA Deubiquitination Upregulates ACLY Expression via H3K18 Lactylation to Promote Lipid Synthesis and Pancreatic Cancer Progression. Co-author DOI 10.1002/advs.202505762 ↗
TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic canc… Co-author DOI 10.1016/j.cellsig.2024.111227 ↗
PELI1: key players in the oncogenic characteristics of pancreatic Cancer. Co-author DOI 10.1186/s13046-024-03008-9 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaobin Fei · 3 shared papers, 2024–2025 · strength 0.65
Likun Ren · 2 shared papers, 2024 · strength 0.42
- Paper TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, inv… DOI 10.1016/j.cellsig.2024.111227 ↗
- Paper PELI1: key players in the oncogenic characteristics of pancreatic Cancer. DOI 10.1186/s13046-024-03008-9 ↗
Xing Wang · 2 shared papers, 2024 · strength 0.42
- Paper TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, inv… DOI 10.1016/j.cellsig.2024.111227 ↗
- Paper PELI1: key players in the oncogenic characteristics of pancreatic Cancer. DOI 10.1186/s13046-024-03008-9 ↗
Songbai Liu · 2 shared papers, 2024 · strength 0.42
- Paper TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, inv… DOI 10.1016/j.cellsig.2024.111227 ↗
- Paper PELI1: key players in the oncogenic characteristics of pancreatic Cancer. DOI 10.1186/s13046-024-03008-9 ↗
Yaozhen Pan · 2 shared papers, 2024 · strength 0.42
- Paper TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, inv… DOI 10.1016/j.cellsig.2024.111227 ↗
- Paper PELI1: key players in the oncogenic characteristics of pancreatic Cancer. DOI 10.1186/s13046-024-03008-9 ↗
Peng Liu · 1 shared paper, 2025 · strength 0.24
- Paper PSMD14-Mediated LDHA Deubiquitination Upregulates ACLY Expression via H3K18 Lactylation to Promote Lipid Synthesis and … DOI 10.1002/advs.202505762 ↗
Xing Wang · 1 shared paper, 2025 · strength 0.24
- Paper PSMD14-Mediated LDHA Deubiquitination Upregulates ACLY Expression via H3K18 Lactylation to Promote Lipid Synthesis and … DOI 10.1002/advs.202505762 ↗
Rishang Lu · 1 shared paper, 2025 · strength 0.24
- Paper PSMD14-Mediated LDHA Deubiquitination Upregulates ACLY Expression via H3K18 Lactylation to Promote Lipid Synthesis and … DOI 10.1002/advs.202505762 ↗
Yaozhen Pan · 1 shared paper, 2025 · strength 0.24
- Paper PSMD14-Mediated LDHA Deubiquitination Upregulates ACLY Expression via H3K18 Lactylation to Promote Lipid Synthesis and … DOI 10.1002/advs.202505762 ↗
Peng Liu · 1 shared paper, 2024 · strength 0.21
- Paper PELI1: key players in the oncogenic characteristics of pancreatic Cancer. DOI 10.1186/s13046-024-03008-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.